Skip to content
StockMarketAgent
Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/0P8 stock hub

FRA/0P8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/0P8is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
10.8B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/0P8
In the news

Latest news · FRA/0P8

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E59.6
P25 n/aP50 n/aP75 n/a
Trailing P/E72.6
P25 n/aP50 n/aP75 n/a
ROE12.7
P25 n/aP50 n/aP75 n/a
ROIC15.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/0P8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
200
Groups with data
11
Currency
USD
Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
4,700
Employees Change
300%
Employees Change Percent
7.14
Enterprise value
EUR 10.4B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Surgical and Medical Instruments and Apparatus
Last refreshed
2026-05-10
Market cap
EUR 10.8B
Price
EUR 273
Price currency
EUR
Rev Per Employee
268,361.63x
Sic
3841
Symbol
fra/0P8
Website
https://www.penumbrainc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
1.38%
EV Earnings
70.29x
EV/EBIT
65.59x
EV/EBITDA
51.22x
EV/FCF
56.52x
EV/Sales
8.44x
FCF yield
1.71%
Forward P/E
59.64x
P/B ratio
8.42x
P/E ratio
72.58x
P/S ratio
8.54x
PE Ratio10 Y
404.22x
PE Ratio3 Y
229.53x
PE Ratio5 Y
459.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
12.87%
EBITDA Margin
14.02%
FCF margin
14.63%
Gross margin
67.38%
Gross Profit
EUR 849.9M
Gross Profit Growth
19.06%
Gross Profit Growth Q
17.38%
Gross Profit Growth3 Y
20.59%
Gross Profit Growth5 Y
20.87%
Net Income
EUR 148.3M
Net Income Growth
305.01%
Net Income Growth Q
-16.93%
Net Income Growth3 Y
197.73%
Pretax Margin
13.96%
Profit Margin
11.76%
Profit Per Employee
EUR 31,564
ROA
6.7
Roa5y
3.13
ROCE
11.09
ROE
12.73
Roe5y
4.69
ROIC
15.22
Roic5y
5.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
18.83%
Cagr1y
7.4%
Cagr3y
-0.84%
Cagr5y
4.17%
EPS Growth
302.4
EPS Growth Q
-18
EPS Growth3 Y
194
Revenue Growth
17.27x
Revenue Growth Q
15.62x
Revenue Growth3 Y
18.02x
Revenue Growth5 Y
19.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.83
Assets
EUR 1.6B
Cash
EUR 534M
Current Assets
EUR 1.1B
Current Liabilities
EUR 179.5M
Debt
EUR 187.5M
Debt EBITDA
EUR 0.9
Debt Equity
EUR 0.15
Debt FCF
EUR 1.02
Equity
EUR 1.3B
Interest Coverage
143.3
Liabilities
EUR 368.3M
Long Term Assets
EUR 565M
Long Term Liabilities
EUR 188.7M
Net Cash
EUR 346.5M
Net Cash By Market Cap
EUR 3.22
Net Cash Growth
152.53%
Net Debt EBITDA
EUR -1.96
Net Debt Equity
EUR -0.27
Net Debt FCF
EUR -1.88
Tangible Book Value
EUR 1.1B
Tangible Book Value Per Share
EUR 28.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.02
Inventory Turnover
1.11
Net Working Capital
EUR 402.9M
Quick ratio
3.77
Working Capital
EUR 922.5M
Working Capital Turnover
EUR 1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
461.28%
1Y total return
7.4%
200-day SMA
253.4
3Y total return
-2.5%
50-day SMA
285
50-day SMA vs 200-day SMA
50over200
5Y total return
22.64%
All Time High
314
All Time High Change
-13.06%
All Time High Date
2023-06-19
All Time Low
31.42
All Time Low Change
768.98%
All Time Low Date
2015-10-22
ATR
2.57
Ch YTD
2.48
High
275.6
High52
306.4
High52 Date
2026-01-21
High52ch
-10.9%
Low
273
Low52
193.1
Low52 Date
2025-11-03
Low52ch
41.38%
Ma50ch
-4.21%
Price vs 200-day SMA
7.71%
RSI
28.86
RSI Monthly
56.66
RSI Weekly
51.13
Sharpe ratio
0.16x
Sortino ratio
0.5
Total Return
-0.45%
Tr YTD
2.48
Tr1m
-3.81%
Tr1w
-1.66%
Tr3m
-4.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
EUR 162.3M
Operating Income Growth
37.21
Operating Income Growth Q
18.05
Operating Income Growth3 Y
121.3
Operating margin
12.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
38,136,650%
Shares Insiders
2.95%
Shares Institutions
83.85%
Shares Qo Q
0.38%
Shares Yo Y
0.45%
Short Ratio
3.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
EUR 132.4M
Average Volume
0x
Bv Per Share
32.5
CAPEX
EUR -55.4M
Ch10y
461.3
Ch1m
-3.81
Ch1w
-1.66
Ch1y
7.4
Ch3m
-4.94
Ch3y
-2.5
Ch5y
22.64
Ch6m
18.75
Change
-1.16%
Change From Open
-0.94
Close
276.2
Days Gap
-0.22
Depreciation Amortization
14,053,910.2
Earnings Date
2026-07-30
EBIT
EUR 162.3M
EBITDA
EUR 176.9M
EPS
EUR 3.76
F Score
6
FCF
EUR 184.5M
FCF EV Yield
1.77x
Financing CF
19,008,614
Fiscal Year End
December
Founded
2,004
Goodwill
141,261,141.6
Graham Number
52.37007
Graham Upside
-80.82
Income Tax
EUR 27.7M
Investing CF
-377,033,523
Is Primary Listing
0
Last Earnings Date
2026-02-23
Last Report Date
2026-03-31
Lynch Fair Value
EUR 94.03
Lynch Upside
-65.56
Ma150
265
Ma150ch
3.01%
Ma20
279.6
Ma20ch
-2.34%
Net CF
-116,881,685
Next Earnings Date
2026-07-30
Open
275.6
P FCF Ratio
58.36
P OCF Ratio
44.87
Position In Range
0
Ppne
279,438,245.4
Price Date
2026-05-08
Price EBITDA
EUR 60.87
Ptbv Ratio
9.54
Relative Volume
2,000x
Revenue
1,261,299,646x
SBC By Revenue
4.13x
Share Based Comp
52,101,313
Tax By Revenue
2.19x
Tax Rate
15.72%
Tr6m
18.75%
Z Score
17.63
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/0P8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0P8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+7.4%
S&P 500 1Y: n/a
3Y total return
-2.5%
S&P 500 3Y: n/a
5Y total return
+22.6%
S&P 500 5Y: n/a
10Y total return
+461.3%
S&P 500 10Y: n/a
Ownership

Who owns FRA/0P8?

Insider, institutional, and short-interest positioning.

Institutional ownership
+83.9%
Share of float held by funds and institutions
Insider ownership
+3.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.4 days to cover
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

FRA/0P8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
28.9
Below 30: short-term oversold
Price vs 200-day MA
+7.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.16
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/0P8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0P8 stock rating?

fra/0P8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0P8 analysis?

The full report lives at /stocks/fra/0P8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0P8?

The latest report frames fra/0P8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0P8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/0P8 stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario